Sarcoma treatment in the era of molecular medicine

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Théry, C., Witwer, K. W., Aikawa, E., Alcaraz, M. J., Anderson, J. D., Andriantsitohaina, R., Antoniou, A., Arab, T., Archer, F., Atkin‐Smith, G. K., et al. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1535750 · Cited by 11,099 · see citing works

3D bioprinting of tissues and organs

Murphy, S. V., & Atala, A. (2014) · Nature Biotechnology · doi:10.1038/nbt.2958 · Cited by 7,034 · see citing works

Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes

Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.035 · Cited by 4,143 · see citing works

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,414 · see citing works

DNA methylation-based classification of central nervous system tumours

Capper, D., Jones, D., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chávez, L., Reuß, D., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,046 · see citing works

A view on drug resistance in cancer

Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770 · see citing works

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Andtbacka, R. H. I., Kaufman, H. L., Collichio, F. A., AMATRUDA, T. T., Senzer, N. N., Chesney, J. A., Delman, K. A., S̄pitler, L. E., Puzanov, I. J., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,646 · see citing works

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

Nejman, D., Livyatan, I., Fuks, G., Gavert, N., Zwang, Y., Geller, L. T., Rotter-Maskowitz, A., Weiser, R., Mallel, G., Gigi, E., et al. (2020) · Science · doi:10.1126/science.aay9189 · Cited by 2,464 · see citing works

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Vlachogiannis, G., Hedayat, S., Vatsiou, A., Jamin, Y., Fernández-Mateos, J., Khan, K., Lampis, A., Eason, K., Huntingford, I., Burke, R., et al. (2018) · Science · doi:10.1126/science.aao2774 · Cited by 2,096 · see citing works

B cells are associated with survival and immunotherapy response in sarcoma

Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942 · see citing works

The Epidemiology of Osteosarcoma

Ottaviani, G., & Jaffe, N. (2009) · Cancer treatment and research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,793 · see citing works

Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy

Ribas, A., Dummer, R., Puzanov, I., VanderWalde, A., Andtbacka, R. H. I., Michielin, O., Olszanski, A. J., Malvehy, J., Cebon, J., Fernandez, E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.08.027 · Cited by 1,520 · see citing works

Cells of origin in cancer

Visvader, J. (2011) · Nature · doi:10.1038/nature09781 · Cited by 1,509 · see citing works

Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin

Snyder, M. W., Kircher, M., Hill, A. J., Daza, R. M., & Shendure, J. (2016) · Cell · doi:10.1016/j.cell.2015.11.050 · Cited by 1,462 · see citing works

Tumor Antigen Escape from CAR T-cell Therapy

Majzner, R. G., & Mackall, C. L. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0442 · Cited by 1,203 · see citing works

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Judson, I. R., Verweij, J., Gelderblom, H. A. J., Hartmann, J. T., Schöffski, P., Blay, J., Kerst, J. M., Šufliarský, J., Whelan, J. S., Hohenberger, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70063-4 · Cited by 1,185 · see citing works

Liquid biopsy and minimal residual disease - latest advances and implications for cure

Pantel, K., & Alix-Panabières, C. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0187-3 · Cited by 1,110 · see citing works

Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer

Tiriac, H., Belleau, P., Engle, D. D., Plenker, D., Deschênes, A., Somerville, T. D. D., Froeling, F. E. M., Burkhart, R. A., Denroche, R. E., Jang, G.-H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0349 · Cited by 1,092 · see citing works

Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas

Abeshouse, A., Adebamowo, C., Adebamowo, S. N., Akbani, R., Akeredolu, T., Ally, A., Anderson, M. L., Anur, P., Appelbaum, E. L., Armenia, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.014 · Cited by 1,069 · see citing works

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Ahmed, N., Brawley, V. S., Hegde, M., Robertson, C., Ghazi, A., Gerken, C., Liu, E., Dakhova, O., Ashoori, A., Corder, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0225 · Cited by 1,004 · see citing works

Genetic and transcriptional evolution alters cancer cell line drug response

Ben-David, U., Siranosian, B., Ha, G., Tang, H., Oren, Y., Hinohara, K., Strathdee, C. A., Dempster, J., Lyons, N. J., Burns, R., et al. (2018) · Nature · doi:10.1038/s41586-018-0409-3 · Cited by 931 · see citing works

The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Helleday, T. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.07.001 · Cited by 859 · see citing works

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

Behjati, S., Tarpey, P. S., Presneau, N., Scheipl, S., Pillay, N., Van Loo, P., Wedge, D. C., Cooke, S. L., Gundem, G., Davies, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2814 · Cited by 854 · see citing works

PDGFRA Mutations in Gastrointestinal Stromal Tumors: Frequency, Spectrum and In Vitro Sensitivity to Imatinib

Corless, C. L., Schroeder, A., Griffith, D., Town, A., McGreevey, L. S., Harrell, P. M., Shiraga, S., Bainbridge, T., Morich, J. R., & Heinrich, M. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.068 · Cited by 848 · see citing works

Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma

Clark, J., Rocques, P. J., Crew, A. J., Gill, S., SHIPLEY, J. M., Chan, A. M.-L., Gusterson, B. A., & Cooper, C. S. (1994) · Nature Genetics · doi:10.1038/ng0894-502 · Cited by 772 · see citing works

Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

Casali, P. G., Abecassis, N., Bauer, S., Biagini, R., Bielack, S., Bonvalot, S., Boukovinas, I., Bovée, J. V. M. G., Brodowicz, T., Broto, J. M., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy095 · Cited by 749 · see citing works

Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis

Eyler, C. E., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1829 · Cited by 742 · see citing works

Comprehensive Genomic Analysis of Rhabdomyosarcoma Reveals a Landscape of Alterations Affecting a Common Genetic Axis in Fusion-Positive and Fusion-Negative Tumors

Shern, J. F., Chen, L., Chmielecki, J., Wei, J. S., Patidar, R., Rosenberg, M. W., Ambrogio, L., Auclair, D., Wang, J., Song, Y. K., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0639 · Cited by 742 · see citing works

Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

Gaspar, N., Hawkins, D. S., Dirksen, U., Lewis, I. J., Ferrari, S., Deley, M. L., Kovar, H., Grimer, R. J., Whelan, J. S., Claude, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.5256 · Cited by 725 · see citing works

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 693 · see citing works

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Majzner, R. G., Theruvath, J. L., Nellan, A., Heitzeneder, S., Cui, Y., Mount, C. W., Rietberg, S. P., Linde, M. H., Xu, P., Rota, C., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0432 · Cited by 681 · see citing works

The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors.

Mankin, H. J., Lange, T. A., & Spanier, S. S. (1982) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198264080-00002 · Cited by 650 · see citing works

PD-L1 expression and prognostic impact in glioblastoma

Nduom, E. K.-E., Wei, J., Yaghi, N. K., Huang, N., Kong, L.-Y., Gabrusiewicz, K. R., Ling, X., Zhou, S., Ivan, C., Chen, J. Q., et al. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov172 · Cited by 600 · see citing works

Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

Tirode, F., Surdez, D., Ma, X., Parker, M. D., Deley, M. L., Bahrami, A., Zhang, Z., Lapouble, E., Grossetête, S., Rusch, M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0622 · Cited by 569 · see citing works

Next-generation sequencing in liquid biopsy: cancer screening and early detection

Chen, M., & Zhao, H. (2019) · Human Genomics · doi:10.1186/s40246-019-0220-8 · Cited by 561 · see citing works

Evaluating the Polarization of Tumor-Associated Macrophages Into M1 and M2 Phenotypes in Human Cancer Tissue: Technicalities and Challenges in Routine Clinical Practice

Jayasingam, S., Citartan, M., Thang, T. H., Zin, A. A. M., Kai, C.-E.-A., & Ch'ng, E. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01512 · Cited by 554 · see citing works

Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells

Keller, L., & Pantel, K. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0180-2 · Cited by 549 · see citing works

Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study.

Rougraff, B. T., Simon, M. A., Kneisl, J. S., Greenberg, D. B., & Mankin, H. J. (1994) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-199405000-00004 · Cited by 534 · see citing works

Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

Buddingh, E. P., Kuijjer, M. L., Duim, R. A. J., Bürger, H., Agelopoulos, K., Myklebost, O., Serra, M., Mertens, F., Hogendoorn, P. C. W., Lankester, A. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2047 · Cited by 508 · see citing works

Genetically engineered mouse models in oncology research and cancer medicine

Kersten, K., de Visser, K. E., van Miltenburg, M. H., & Jonkers, J. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201606857 · Cited by 502 · see citing works

Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481 · see citing works

Lysosomes as mediators of drug resistance in cancer

Zhitomirsky, B., & Assaraf, Y. G. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.11.004 · Cited by 480 · see citing works

Osteosarcoma, Chondrosarcoma, and Chordoma

Whelan, J. S., & Davis, L. E. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.1743 · Cited by 477 · see citing works

Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.

Simon, M. A., Aschliman, M. A., Thomas, N., & Mankin, H. J. (1986) · Journal of Bone and Joint Surgery · doi:10.2106/00004623-198668090-00005 · Cited by 469 · see citing works

Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

Stiller, C. A., Trama, A., Brewster, D., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos‐Gragera, R., Visser, O. J., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463 · see citing works

Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications

Jeyaram, A., & Jay, S. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0160-y · Cited by 461 · see citing works

Limb-Salvage Treatment Versus Amputation for Osteosarcoma of the Distal End of the Femur

Simon, M. A., Aschliman, M. A., Thomas, N. J., & Mankin, H. J. (2005) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.8712.cl · Cited by 452 · see citing works

Genome-Informed Targeted Therapy for Osteosarcoma

Sayles, L. C., Breese, M. R., Koehne, A. L., Leung, S. G., Lee, A. G., Liu, H.-Y., Spillinger, A., Shah, A. T., Tanasa, B., Straessler, K., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1152 · Cited by 452 · see citing works

EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma

Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 447 · see citing works

Biological Laser Printing: A Novel Technique for Creating Heterogeneous 3-dimensional Cell Patterns

Barron, J. A., Wu, P., Ladouceur, H. D., & Ringeisen, B. R. (2004) · Biomedical Microdevices · doi:10.1023/b:bmmd.0000031751.67267.9f · Cited by 437 · see citing works

Inferring expressed genes by whole-genome sequencing of plasma DNA

Ulz, P., Thallinger, G., Auer, M., Graf, R., Kashofer, K., Jahn, S. W., Abete, L., Pristauz, G., Petru, E., Geigl, J. B., et al. (2016) · Nature Genetics · doi:10.1038/ng.3648 · Cited by 432 · see citing works

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma

D’Angelo, S. P., Melchiori, L., Merchant, M. S., Bernstein, D. B., Glod, J. W., Kaplan, R. N., Grupp, S. A., Tap, W. D., Chagin, K., Binder, G. K., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1417 · Cited by 432 · see citing works

Bioprinting for vascular and vascularized tissue biofabrication

Datta, P., Ayan, B., & Ozbolat, I. T. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.035 · Cited by 431 · see citing works

Advances in sarcoma genomics and new therapeutic targets

Taylor, B. S., Barretina, J. G., Maki, R. G., Antonescu, C. R., Singer, S., & Ladanyi, M. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3087 · Cited by 428 · see citing works

Patient-derived orthotopic xenografts: better mimic of metastasis than subcutaneous xenografts

Hoffman, R. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3972 · Cited by 424 · see citing works

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

Naumov, G. N., Bender, E., Zurakowski, D., Kang, S.-Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj068 · Cited by 423 · see citing works

A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation

Michel, B. C., D’Avino, A. R., Cassel, S. H., Mashtalir, N., McKenzie, Z. M., McBride, M. J., Valencia, A. M., Zhou, Q., Bocker, M., Soares, L. M. M., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0221-1 · Cited by 423 · see citing works

Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial

Blay, J., Serrano, C., Heinrich, M. C., Zalcberg, J. R., Bauer, S., Gelderblom, H. A. J., Schöffski, P., Jones, R. L., Attia, S., D’Amato, G. Z., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30168-6 · Cited by 422 · see citing works

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling

Ma, X., Liu, J., Zhu, W. Z., Tang, M., Lawrence, N., Yu, C., Gou, M., & Chen, S. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.06.011 · Cited by 408 · see citing works

Use of PD-1 Targeting, Macrophage Infiltration, and IDO Pathway Activation in Sarcomas

Toulmonde, M., Penel, N., Adam, J., Chevreau, C., Blay, J., Cesne, A. L., Bompas, E., Piperno-Neumann, S., Cousin, S., Grellety, T., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.1617 · Cited by 402 · see citing works

Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced <i>CDK4</i> -Amplified Well-Differentiated or Dedifferentiated Liposarcoma

Dickson, M. A., Tap, W. D., Keohan, M. L., D'Angelo, S. P., Gounder, M. M., Antonescu, C. R., Landa, J., Qin, L.-X., Rathbone, D. D., Condy, M. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.5476 · Cited by 399 · see citing works

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Doebele, R. C., Davis, L. E., Vaishnavi, A., Le, A. T., Estrada‐Bernal, A., Keysar, S. B., Jimeno, A., Varella‐Garcia, M., Aisner, D. L., Li, Y., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0443 · Cited by 398 · see citing works

Expression of P-Glycoprotein in High-Grade Osteosarcomas in Relation to Clinical Outcome

Baldini, N., Scotlandi, K., Bròdano, G. B., Manara, M. C., Maurici, D., Bacci, G., Bertoni, F., Picci, P., Sottili, S., Campanacci, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332103 · Cited by 396 · see citing works

Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape

Lü, C., Jain, S. U., Hoelper, D., Béchet, D., Molden, R. C., Ran, L., Murphy, D. A., Venneti, S., Hameed, M., Pawel, B., et al. (2016) · Science · doi:10.1126/science.aac7272 · Cited by 392 · see citing works

Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche

Lawson, M. A., McDonald, M. M., Kovačić, N., Khoo, W. H., Terry, R. L., Down, J. M., Kaplan, W. H., Paton‐Hough, J., Fellows, C., Pettitt, J. A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9983 · Cited by 385 · see citing works

The expanding landscape of ‘oncohistone’ mutations in human cancers

Nacev, B. A., Feng, L., Bagert, J. D., Lemiesz, A. E., Gao, J., Soshnev, A. A., Kundra, R., Schultz, N., Muir, T. W., & Allis, C. D. (2019) · Nature · doi:10.1038/s41586-019-1038-1 · Cited by 384 · see citing works

Pathology image analysis using segmentation deep learning algorithms

Wang, S., Yang, D. M., Rong, R., Zhan, X., & Xiao, G. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.05.007 · Cited by 382 · see citing works

Improved survival using specialized multidisciplinary board in sarcoma patients

Blay, J., Soibinet, P., Penel, N., Bompas, E., Duffaud, F., Stoeckle, E., Mir, O., Adam, J., Chevreau, C., Bonvalot, S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx484 · Cited by 370 · see citing works

Autophagy, cancer stem cells and drug resistance

Smith, A. G., & Macleod, K. F. (2018) · The Journal of Pathology · doi:10.1002/path.5222 · Cited by 364 · see citing works

Targeting Cancer Cell Dormancy

Recasens, A., & Munoz, L. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.12.004 · Cited by 356 · see citing works

Gene expression profiling of human sarcomas: insights into sarcoma biology.

Baird, K., Davis, S., Antonescu, C. R., Harper, U. L., Walker, R. L., Chen, Y., Glatfelter, A. A., Duray, P. H., & Meltzer, P. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1699 · Cited by 353 · see citing works

Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

Kovac, M., Blattmann, C., Ribi, S., Smida, J., Mueller, N. S., Engert, F., Castro-Giner, F., Weischenfeldt, J., Kovacova, M., Krieg, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms9940 · Cited by 353 · see citing works

Osteoblasts are target cells for transformation in c-fos transgenic mice

Grigoriadis, A. E., Schellander, K., Wang, Z., & Wagner, E. F. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.3.685 · Cited by 349 · see citing works

Multi-omic measurements of heterogeneity in HeLa cells across laboratories

Liu, Y., Mi, Y., Mueller, T., Kreibich, S., Williams, E. G., Van Drogen, A., Borel, C., Frank, M., Germain, P.-L., Bludau, I., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0037-y · Cited by 338 · see citing works

Transcriptomic definition of molecular subgroups of small round cell sarcomas

Watson, S., Perrin, V., Guillemot, D., Reynaud, S., Coindre, J., Karanian, M., Guinebretière, J., Fréneaux, P., Loarer, F. L., Bouvet, M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5053 · Cited by 335 · see citing works

Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors

Merchant, M. S., Wright, M., Baird, K., Wexler, L. H., Rodriguez-Galindo, C., Bernstein, D., Delbrook, C., Lodish, M., Bishop, R., Wolchok, J. D., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0491 · Cited by 331 · see citing works

Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial

Heinrich, M. C., Jones, R. L., von Mehren, M., Schöffski, P., Serrano, C., Kang, Y., Cassier, P. A., Mir, O., Eskens, F. A. L. M., Tap, W. D., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30269-2 · Cited by 325 · see citing works

PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability

Gryder, B. E., Yohe, M. E., Chou, H.-C., Zhang, X., Marques, J. G., Wachtel, M., Schaefer, B. W., Sen, N., Song, Y., Gualtieri, A., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1297 · Cited by 317 · see citing works

MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis

Musa, J., Aynaud, M.-M., Mirabeau, O., Delattre, O., & Grünewald, T. G. P. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.244 · Cited by 315 · see citing works

HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma

Xiao, X., Wang, W., Li, Y., Yang, D., Li, X., Shen, C., Liu, Y., Ke, X., Guo, S., & Guo, Z. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0880-6 · Cited by 313 · see citing works

Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of functionPreprint

Keller, C., Arenkiel, B. R., Coffin, C. M., Bardeesy, N. M., DePinho, R. A., & Capecchi, M. R. (2004) · Genes & Development · doi:10.1101/gad.1244004 · Cited by 304 · see citing works

Cancer stem cells in osteosarcoma

Brown, H. K., Tellez-Gabriel, M., & Heymann, D. (2017) · Cancer Letters · doi:10.1016/j.canlet.2016.11.019 · Cited by 303 · see citing works

Integrative genomic and transcriptomic analysis of leiomyosarcoma

Chudasama, P., Mughal, S. S., Sanders, M. A., Hübschmann, D., Chung, I., Deeg, K. I., Wong, S.-H., Rabe, S., Hlevnjak, M., Zapatka, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02602-0 · Cited by 303 · see citing works

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

D’Angelo, S. P., Shoushtari, A. N., Agaram, N. P., Kuk, D., Qin, L., Carvajal, R. D., Dickson, M. A., Gounder, M. M., Keohan, M. L., Schwartz, G. K., et al. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.11.001 · Cited by 300 · see citing works

From the archives of the AFIP. Extraskeletal osseous and cartilaginous tumors of the extremities.

Kransdorf, M. J., & Meis, J. M. (1993) · Radiographics · doi:10.1148/radiographics.13.4.8356273 · Cited by 292 · see citing works

Orthotopic patient-derived xenografts of paediatric solid tumours

Stewart, E., Federico, S. M., Chen, X., Shelat, A. A., Bradley, C., Gordon, B., Karlstrom, A., Twarog, N. R., Clay, M. R., Bahrami, A., et al. (2017) · Nature · doi:10.1038/nature23647 · Cited by 286 · see citing works

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki, K., Fueyo-Margareto, J., Krasnykh, V. N., Reynolds, P. N., Curiel, D. T., & Alemany, R. (2001) · PubMed · Cited by 286 · see citing works

The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas

Fang, D., Gan, H., Lee, J., Han, J., Wang, Z., Riester, S. M., Jin, L. G., Chen, J., Zhou, H., Wang, J., et al. (2016) · Science · doi:10.1126/science.aae0065 · Cited by 285 · see citing works

Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas

Kim, J. R., Moon, Y. J., Kwon, K. S., Bae, J. S., Wagle, S., Kim, K. M., Park, H. S., Lee, H., Moon, W. S., Chung, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082870 · Cited by 284 · see citing works

Causes, consequences, and therapy of tumors acidosis

Pillai, S., Damaghi, M., Marunaka, Y., Spugnini, E. P., Fais, S., & Gillies, R. J. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09792-7 · Cited by 282 · see citing works

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

El-Naggar, A. M., Veinotte, C. J., Cheng, H., Grünewald, T. G. P., Negri, G. L., Somasekharan, S. P., Corkery, D., Tirode, F., Mathers, J. A., Khan, D., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.04.003 · Cited by 280 · see citing works

EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cellsPreprint

Riggi, N., Suvà, M.-L., Vito, C. D., Provero, P., Stehle, J., Baumer, K., Cironi, L., Janiszewska, M., Petricevic, T., Suvà, D., et al. (2010) · Genes & Development · doi:10.1101/gad.1899710 · Cited by 279 · see citing works

T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas

Pollack, S. M., He, Q., Yearley, J. H., Emerson, R., Vignali, M., Zhang, Y., Redman, M. W., Baker, K. K., Cooper, S., Donahue, B., et al. (2017) · Cancer · doi:10.1002/cncr.30726 · Cited by 274 · see citing works

Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors

Vaira, V., Fedele, G., Pyne, S., Fasoli, E., Zadra, G., Bailey, D., Snyder, E. L., Faversani, A., Coggi, G., Flavin, R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907676107 · Cited by 269 · see citing works

Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma

Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30093 · Cited by 267 · see citing works

A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors

Nemunaitis, J. J., Tong, A. W., Nemunaitis, M., Senzer, N. N., Phadke, A. P., Bedell, C., Adams, N., Zhang, Y.-A., Maples, P. B., Chen, S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2009.262 · Cited by 266 · see citing works

Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma

Behjati, S., Tarpey, P. S., Haase, K., Ye, H., Young, M. D., Alexandrov, L. B., Farndon, S. J., Collord, G., Wedge, D. C., Martincorena, I., et al. (2017) · Nature Communications · doi:10.1038/ncomms15936 · Cited by 261 · see citing works

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

Sheffield, N. C., Pierron, G., Klughammer, J., Datlinger, P., Schönegger, A., Schuster, M. K., Hadler, J. S., Surdez, D., Guillemot, D., Lapouble, E., et al. (2017) · Nature Medicine · doi:10.1038/nm.4273 · Cited by 254 · see citing works

Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases.

Cao, Y., OʼReilly, M., Marshall, B., Flynn, E. A., Ji, R. W., & Folkman, J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1558 · Cited by 251 · see citing works

Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells

Basu-Roy, U., Bayin, N. S., Rattanakorn, K., Han, E. J., Placantonakis, D. G., Mansukhani, A., & Basilico, C. (2015) · Nature Communications · doi:10.1038/ncomms7411 · Cited by 248 · see citing works

Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy

Demetri, G. D., Chawla, S. P., Ray-Coquard, I., Le Cesne, A., Staddon, A. P., Milhem, M. M., Penel, N., Riedel, R. F., Bui-Nguyen, B., Cranmer, L. D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5766 · Cited by 245 · see citing works

A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis

Moriarity, B. S., Otto, G. M., Rahrmann, E. P., Rathe, S. K., Wolf, N. K., Weg, M. T., Manlove, L. A., LaRue, R. S., Temiz, N. A., Molyneux, S. D., et al. (2015) · Nature Genetics · doi:10.1038/ng.3293 · Cited by 240 · see citing works

Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1

Tomazou, E. M., Sheffield, N. C., Schmidl, C., Schuster, M. K., Schönegger, A., Datlinger, P., Kubicek, S., Bock, C., & Kovar, H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.042 · Cited by 240 · see citing works

3D printing of biomimetic microstructures for cancer cell migration

Huang, T. Q., Qu, X., Liu, J., & Chen, S. (2013) · Biomedical Microdevices · doi:10.1007/s10544-013-9812-6 · Cited by 238 · see citing works

Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas

Basu-Roy, U., Seo, E., Ramanathapuram, L. V., Rapp, T. B., Perry, J. A., Orkin, S. H., Mansukhani, A., & Basilico, C. (2011) · Oncogene · doi:10.1038/onc.2011.405 · Cited by 238 · see citing works

Circulating Tumor Cells: A Review of Non–EpCAM-Based Approaches for Cell Enrichment and Isolation

Gabriel, M. T., Calleja, L. R., Chalopin, A., Ory, B., & Heymann, D. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.249706 · Cited by 238 · see citing works

The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma

Heymann, M.-F., Lézot, F., & Heymann, D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.011 · Cited by 233 · see citing works

NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction

Gaude, E., Schmidt, C., Gammage, P. A., Dugourd, A. J. F., Blacker, T. S., Peak‐Chew, S., Sáez-Rodríguez, J., O'Neill, J. S., Szabadkai, G., Minczuk, M. A., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.034 · Cited by 229 · see citing works

Laser Printing of Single Cells: Statistical Analysis, Cell Viability, and Stress

Barron, J. A., Krizman, D. B., & Ringeisen, B. R. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8971-x · Cited by 227 · see citing works

MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors.

Jaboin, J. J., Wild, J., Hamidi, H., Khanna, C., Kim, C. J., Robey, R. W., Bates, S. E., & Thiele, C. J. (2002) · PubMed · Cited by 226 · see citing works

Liquid Biopsy: Current Status and Future Perspectives

Mader, S., & Pantel, K. (2017) · Oncology Research and Treatment · doi:10.1159/000478018 · Cited by 226 · see citing works

Bone microenvironment signals in osteosarcoma development

Alfranca, A., Martínez-Cruzado, L., Tornín, J., Abarrategi, A., Amaral, A. T., de Álava, E., Menéndez, P. R., Garcı́a-Castro, J., & Rodrı́guez, R. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1918-y · Cited by 225 · see citing works

Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein

Salanti, A., Clausen, T. M., Agerbæk, M. Ø., Al-Nakouzi, N., Dahlbäck, M., Oo, H. Z., Lee, S., Gustavsson, T., Rich, J. R., Hedberg, B. J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.003 · Cited by 221 · see citing works

Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma

Brien, G. L., Remillard, D., Shi, J., Hemming, M. L., Chabon, J., Wynne, K. J., Dillon, E., Cagney, G., van Mierlo, G., Baltissen, M. P. A., et al. (2018) · eLife · doi:10.7554/elife.41305 · Cited by 217 · see citing works

Musculoskeletal Tumors: How to Use Anatomic, Functional, and Metabolic MR Techniques

Fayad, L. M., Jacobs, M. A., Wang, X., Carrino, J. A., & Bluemke, D. A. (2012) · Radiology · doi:10.1148/radiol.12111740 · Cited by 217 · see citing works

Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab

Keung, E. Z., Burgess, M., Salazar, R., Parra, E. R., Rodrigues-Canales, J., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Attia, S., Riedel, R. F., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1824 · Cited by 215 · see citing works

Osteosarcoma: Cells‐of‐Origin, Cancer Stem Cells, and Targeted Therapies

Abarrategi, A., Tornín, J., Martínez-Cruzado, L., Hamilton, A., Martínez‐Campos, E., Rodrigo, J. P., González, M. V., Baldini, N., Garcı́a-Castro, J., & Rodrı́guez, R. (2016) · Stem Cells International · doi:10.1155/2016/3631764 · Cited by 211 · see citing works

A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications

Volckmar, A., Sültmann, H., Riediger, A. L., Fioretos, T., Schirmacher, P., Endris, V., Stenzinger, A., & Dietz, S. (2017) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22517 · Cited by 207 · see citing works

Synovial Sarcoma Is a Stem Cell Malignancy

Naka, N., Takenaka, S., Araki, N., Miwa, T., Hashimoto, N., Yoshioka, K., Joyama, S., Hamada, K., Tsukamoto, Y., Tomita, Y., et al. (2010) · Stem Cells · doi:10.1002/stem.452 · Cited by 205 · see citing works

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance

Angelis, M. L. D., Francescangeli, F., Torre, F. L., & Zeuner, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00626 · Cited by 203 · see citing works

Interleukin‐34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment

Ségaliny, A. I., Mohamadi, A., Dizier, B., Lokajczyk, A., Brion, R., Lanel, R., Amiaud, J., Charrier, C., Boisson‐Vidal, C., & Heymann, D. (2015) · International Journal of Cancer · doi:10.1002/ijc.29376 · Cited by 199 · see citing works

Interleukin-6 Blood Level Is Associated With Circulating Carcinoembryonic Antigen and Prognosis in Patients With Colorectal Cancer

Belluco, C., Nitti, D., Frantz, M., Toppan, P., Basso, D., Plebani, M., Lise, M., & Jessup, J. M. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0133-7 · Cited by 196 · see citing works

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study

Italiano, A., Mauro, I. D., Rapp, J., Pierron, G., Auger, N., Alberti, L., Chibon, F., Escande, F., Voegeli, A., Ghnassia, J., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00583-5 · Cited by 191 · see citing works

Exosome-Derived miR-25-3p and miR-92a-3p Stimulate Liposarcoma Progression

Casadei, L., Calore, F., Creighton, C. J., Guescini, M., Batte, K., Iwenofu, O. H., Zewdu, A., Braggio, D., Bill, K. L. J., Fadda, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2984 · Cited by 191 · see citing works

Untitled work

(2003) · PubMed · Cited by 190 · see citing works

Blocking Tumor-Educated MSC Paracrine Activity Halts Osteosarcoma Progression

Baglio, S. R., Lagerweij, T., Pérez-Lanzón, M., Ho, X. D., Léveillé, N., Melo, S. A., Cleton-Jansen, A.-M., Jordanova, E. S., Roncuzzi, L., Greco, M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2726 · Cited by 187 · see citing works

Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer.

Kumar, H., Heer, K., Lee, P. W. R., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J., & Monson, J. R. T. (1998) · PubMed · Cited by 187 · see citing works

Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer

Vallette, F. M., Olivier, C., Lézot, F., Oliver, L., Cochonneau, D., Lalier-Bretaudeau, L., Cartron, P., & Heymann, D. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.004 · Cited by 184 · see citing works

Targeting the DNA Repair Pathway in Ewing Sarcoma

Stewart, E. A., Goshorn, D. R., Bradley, C. L., Griffiths, L. M., Benavente, C. A., Twarog, N. R., Miller, G. M., Caufield, W. V., Freeman, B. B., Bahrami, A., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.09.028 · Cited by 179 · see citing works

CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial

Gomez‐Brouchet, A., Illac, C., Gilhodes, J., Bouvier, C., Aubert, S., Guinebretière, J., Marie, B., Larousserie, F., Entz‐Werlé, N., Pinieux, G. D. B. D., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1331193 · Cited by 179 · see citing works

Dormancy in cancer

Endo, H., & Inoue, M. (2018) · Cancer Science · doi:10.1111/cas.13917 · Cited by 178 · see citing works

A General MRI-CEST Ratiometric Approach for pH Imaging: Demonstration of in Vivo pH Mapping with Iobitridol

Longo, D. L., Sun, P. Z., Consolino, L., MICHELOTTI, F. C., Uggeri, F., & Aime, S. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5059313 · Cited by 176 · see citing works

Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma

Dumars, C., Ngyuen, J.-M., Gaultier, A., Lanel, R., Corradini, N., Gouin, F., Heymann, D., & Heymann, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13055 · Cited by 174 · see citing works

Treatment pathway of bone sarcoma in children, adolescents, and young adults

Reed, D. R., Hayashi, M., Wagner, L. M., Binitie, O. T., Steppan, D. A., Brohl, A. S., Shinohara, E. T., Bridge, J. A., Loeb, D. M., Borinstein, S. C., et al. (2017) · Cancer · doi:10.1002/cncr.30589 · Cited by 174 · see citing works

Universal Marker and Detection Tool for Human Sarcoma Circulating Tumor Cells

Satelli, A., Mitra, A., Cutrera, J. J., Devarie, M., Xia, X., Ingram, D. R., Dibra, D., Somaiah, N., Torres, K. E., Ravi, V., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1739 · Cited by 173 · see citing works

Mesenchymal stroma: Role in osteosarcoma progression

Cortini, M., Avnet, S., & Baldini, N. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.07.024 · Cited by 171 · see citing works

Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance

Kilic, M., Kasperczyk, H., Fulda, S., & Debatin, K. (2006) · Oncogene · doi:10.1038/sj.onc.1210008 · Cited by 167 · see citing works

Advances in immune checkpoint inhibitors for bone sarcoma therapy

Thanindratarn, P., Dean, D. C., Nelson, S. D., Hornicek, F. J., & Duan, Z. (2019) · Journal of bone oncology · doi:10.1016/j.jbo.2019.100221 · Cited by 166 · see citing works

Biology of Bone Sarcomas and New Therapeutic Developments

Brown, H. K., Schiavone, K., Gouin, F., Heymann, M.-F., & Heymann, D. (2018) · Calcified Tissue International · doi:10.1007/s00223-017-0372-2 · Cited by 163 · see citing works

Imaging tumor acidosis: a survey of the available techniques for mapping in vivo tumor pH

Anemone, A., Consolino, L., Arena, F., Capozza, M., & Longo, D. L. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09782-9 · Cited by 163 · see citing works

Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma

Gryder, B. E., Pomella, S., Sayers, C. M., Wu, X., Song, Y., Chiarella, A. M., Bagchi, S., Chou, H.-C., Sinniah, R., Walton, A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0534-4 · Cited by 162 · see citing works

Phase 1 Study of Intratumoral Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus, in Pediatric Cancer Patients

Cripe, T. P., Ngo, M. C., Geller, J. I., Louis, C. U., Currier, M. A., Racadio, J. M., Towbin, A. J., Rooney, C. M., Pelusio, A., Moon, A., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.243 · Cited by 160 · see citing works

Local Recurrence of Disease after Unplanned Excisions of High-grade Soft Tissue Sarcomas

Potter, B. K., Adams, S. C., Pitcher, D. J., & Temple, T. H. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-008-0529-4 · Cited by 160 · see citing works

The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma

Banito, A., Li, X., Laporte, A. N., Roe, J., Sánchez-Vega, F., Huang, C., Dancsok, A. R., Hatzi, K., Chen, C.-C., Tschaharganeh, D. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.018 · Cited by 158 · see citing works

Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas

Dudeck, O., Zeile, M., Pink, D., Pech, M., Tunn, P., Reichardt, P., Ludwig, W., & Hamm, B. (2008) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21358 · Cited by 157 · see citing works

In Vivo Imaging of Tumor Metabolism and Acidosis by Combining PET and MRI-CEST pH Imaging

Longo, D. L., Bartoli, A., Consolino, L., Bardini, P., Arena, F., Schwaiger, M., & Aime, S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0825 · Cited by 157 · see citing works

Patient‐derived xenografts for individualized care in advanced sarcoma

Stebbing, J., Paz, K., Schwartz, G. K., Wexler, L. H., Maki, R. G., Pollock, R. E., Morris, R., Cohen, R., Shankar, A., Blackman, G., et al. (2014) · Cancer · doi:10.1002/cncr.28696 · Cited by 156 · see citing works

CD163 + M2-type tumor-associated macrophage support the suppression of tumor-infiltrating T cells in osteosarcoma

Han, Q., Shi, H., & Liu, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.023 · Cited by 149 · see citing works

Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group

Shulman, D. S., Klega, K., Imamovic-Tuco, A., Clapp, A., Nag, A., Thorner, A. R., Van Allen, E., Ha, G., Lessnick, S. L., Gorlick, R., et al. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0212-9 · Cited by 149 · see citing works

Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle

Lamoureux, F., Baud’huin, M., Calleja, L. R., Jacques, C., Berreur, M., Rédiní, F., Lecanda, F., Bradner, J. E., Heymann, D., & Ory, B. (2014) · Nature Communications · doi:10.1038/ncomms4511 · Cited by 148 · see citing works

Epithelial-to-Mesenchymal and Mesenchymal-to-Epithelial Transition in Mesenchymal Tumors: A Paradox in Sarcomas?

Sannino, G., Marchetto, A., Kirchner, T., & Grünewald, T. G. P. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0032 · Cited by 145 · see citing works

Intratumoral Injection of HSV1716, an Oncolytic Herpes Virus, Is Safe and Shows Evidence of Immune Response and Viral Replication in Young Cancer Patients

Streby, K. A., Geller, J. I., Currier, M. A., Warren, P. S., Racadio, J. M., Towbin, A. J., Vaughan, M. R., Triplet, M., Ott-Napier, K., Dishman, D. J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2900 · Cited by 144 · see citing works

Modeling sarcomagenesis using multipotent mesenchymal stem cells

Rodrı́guez, R., Rubio, R., & Menéndez, P. R. (2011) · Cell Research · doi:10.1038/cr.2011.157 · Cited by 143 · see citing works

Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance

Honoki (2010) · Oncology Reports · doi:10.3892/or_00000885 · Cited by 143 · see citing works

Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia

Killander, D., Dohlwitz, A., Engstedt, L., Franzén, S., Gahrton, G., GULLBRING, B., Holm, G., Holmgren, A., Höglund, S., KILLANDER, A., et al. (1976) · Cancer · doi:10.1002/1097-0142(197601)37:1 · Cited by 143 · see citing works

MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition

Kovatcheva, M., Liu, D. D., Dickson, M. A., Klein, M. E., O’Connor, R., Wilder, F. O., Socci, N. D., Tap, W. D., Schwartz, G. K., Singer, S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3364 · Cited by 142 · see citing works

Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations

Koelsche, C., Mynarek, M., Schrimpf, D., Bertero, L., Serrano, J., Sahm, F., Reuß, D., Hou, Y., Baumhoer, D., Vokuhl, C., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1871-6 · Cited by 142 · see citing works

Functional Interactions between Tumor and Peripheral Nerve: Changes in Excitability and Morphology of Primary Afferent Fibers in a Murine Model of Cancer Pain

Cain, D. M., Wacnik, P. W., Turner, M., Wendelschafer‐Crabb, G., Kennedy, W. R., Wilcox, G. L., & Simone, D. A. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09367.2001 · Cited by 141 · see citing works

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells

Bonuccelli, G., Avnet, S., Grisendi, G., Salerno, M., Granchi, D., Dominici, M., Kusuzaki, K., & Baldini, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2243 · Cited by 140 · see citing works

CD8 + /FOXP3 + -ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study

Fritzsching, B., Fellenberg, J., Moskovszky, L. E., Sápi, Z., Krenács, T., Machado, I., Poeschl, J., Lehner, B., Szendrői, M., Bosch, A. L., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990800 · Cited by 140 · see citing works

Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts

Tarnowski, M., Grymula, K., Liu, R., Tarnowska, J., Drukala, J., Ratajczak, J., Mitchell, R. A., Ratajczak, M. Z., & Kucia, M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0288 · Cited by 136 · see citing works

Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation

Avnet, S., Pompo, G. D., Chano, T., Errani, C., Ibrahim‐Hashim, A., Gillies, R. J., Donati, D. M., & Baldini, N. (2016) · International Journal of Cancer · doi:10.1002/ijc.30540 · Cited by 133 · see citing works

Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways

Steele, C. D., Tarabichi, M., Oukrif, D., Webster, A. P., Ye, H., Fittall, M. W., Lombard, P., Martincorena, I., Tarpey, P. S., Collord, G., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.002 · Cited by 132 · see citing works

Genomic landscape of liposarcoma

Kanojia, D., Nagata, Y., Garg, M., Lee, D. H., Sato, A., Yoshida, K., Sato, Y., Sanada, M., Mayakonda, A., Bartenhagen, C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6464 · Cited by 132 · see citing works

A Mouse Model of Rhabdomyosarcoma Originating from the Adipocyte Lineage

Hatley, M. E., Tang, W., Garcia, M. R., Finkelstein, D., Millay, D. P., Liu, N., Graff, J. M., Galindo, R. L., & Olson, E. N. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.004 · Cited by 131 · see citing works

East Siberian Arctic inland waters emit mostly contemporary carbon

Dean, J. F., Meisel, O. H., Rosco, M. M., Marchesini, L. B., Garnett, M. H., Lenderink, H., van Logtestijn, R. S. P., Borges, A. V., Bouillon, S., Lambert, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15511-6 · Cited by 131 · see citing works

Cats, Cancer and Comparative Oncology

Cannon, C. M. (2015) · Veterinary Sciences · doi:10.3390/vetsci2030111 · Cited by 128 · see citing works

Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group

Roberts, R. D., Lizardo, M. M., Reed, D. R., Hingorani, P., Glover, J., Allen‐Rhoades, W., Fan, T., Khanna, C., Sweet‐Cordero, E. A., Cash, T., et al. (2019) · Cancer · doi:10.1002/cncr.32351 · Cited by 127 · see citing works

Correlations between 31 P-NMR Spectroscopy and Tissue O 2 Tension Measurements in a Murine Fibrosarcoma

Vaupel, P. W., Okunieff, P., Kallinowski, F., & Neuringer, L. J. (1989) · Radiation Research · doi:10.2307/3577798 · Cited by 126 · see citing works

Unplanned Excision of Soft-Tissue Sarcomas

Pretell-Mazzini, J. A., Barton, M. D., Conway, S. A., & Temple, H. T. (2015) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.n.00649 · Cited by 123 · see citing works

Zebrafish xenograft models of cancer and metastasis for drug discovery

Brown, H. K., Schiavone, K., Tazzyman, S. J., Heymann, D., & Chico, T. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2017.1297416 · Cited by 122 · see citing works

Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression

Rodríguez-García, A., Giménez-Alejandre, M., Rojas, J. J., Moreno, R., Bazán‐Peregrino, M., Cascalló, M., & Alemany, R. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2213 · Cited by 119 · see citing works

Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: Correlations with local tumor extent and prognosis

Rutkowski, P. L., Kaminska, J. A., Kowalska, M. M., Ruka, W., & Steffen, J. A. (2003) · Journal of Surgical Oncology · doi:10.1002/jso.10305 · Cited by 117 · see citing works

Administration of a Tropomyosin Receptor Kinase Inhibitor Attenuates Sarcoma-Induced Nerve Sprouting, Neuroma Formation and Bone Cancer Pain

Ghilardi, J. R., Freeman, K. T., Jiménez‐Andrade, J. M., Mantyh, W. G., Bloom, A. P., Kuskowski, M. A., & Mantyh, P. W. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-87 · Cited by 117 · see citing works

Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma

Lamora, A., Talbot, J., Bougras-Cartron, G., Amiaud, J., Leduc, M., Chesneau, J., Taurelle, J., Stresing, V., Deley, M. L., Heymann, M., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3191 · Cited by 114 · see citing works

Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis

Almog, N., Henke, V. G., Flores, L. M., Hlatky, L., Kung, A. L., Wright, R. D., Berger, R., Hutchinson, L., Naumov, G. N., Bender, E. R., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-3946fje · Cited by 112 · see citing works

Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling

Martins‐Neves, S. R., Paiva‐Oliveira, D. I., Wijers‐Koster, P. M., Abrunhosa, A., Ribeiro, C., Bovée, J. V. M. G., Cleton-Jansen, A., & Gomes, C. M. F. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.013 · Cited by 112 · see citing works

Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients

Riethmüller, G., & Klein, C. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0386 · Cited by 112 · see citing works

Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment

Indraccolo, S., Stievano, L., Minuzzo, S. A., Tosello, V., Esposito, G., Piovan, E., Zamarchi, R., Chieco‐Bianchi, L., & Amadori, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506200103 · Cited by 112 · see citing works

Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy

Sundara, Y. T., Kostine, M., Cleven, A. H. G., Bovée, J. V. M. G., Schilham, M. W., & Cleton-Jansen, A.-M. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-016-1925-3 · Cited by 111 · see citing works

Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity

Gabriel, M. T., Heymann, M., & Heymann, D. (2019) · Theranostics · doi:10.7150/thno.34337 · Cited by 111 · see citing works

Pediatric Cancers Are Infiltrated Predominantly by Macrophages and Contain a Paucity of Dendritic Cells: a Major Nosologic Difference with Adult Tumors

Vakkila, J., Jaffe, R., Michelow, M., & Lotze, M. T. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1824 · Cited by 110 · see citing works

Transforming Growth Factor β1 Signal is Crucial for Dedifferentiation of Cancer Cells to Cancer Stem Cells in Osteosarcoma

Zhang, H., Wu, H., Zheng, J., Yu, P., Xu, L., Jiang, P., Gao, J., Wang, H., & Zhang, Y. (2012) · Stem Cells · doi:10.1002/stem.1298 · Cited by 109 · see citing works

Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic information

Koelsche, C., Hartmann, W., Schrimpf, D., Stichel, D., Jabar, S., Ranft, A., Reuß, D., Sahm, F., Jones, D., Bewerunge‐Hudler, M., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0045-3 · Cited by 108 · see citing works

The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review

Rugo, H. S., Jacobs, I. A., Sharma, S., Scappaticci, F. A., Paul, T. A., Jensen-Pergakes, K., & Malouf, G. G. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01379-x · Cited by 108 · see citing works

The Role of 18 F-FDG-PET/CT in Pediatric Sarcoma

Harrison, D. J., Parisi, M. T., & Shulkin, B. L. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2016.12.004 · Cited by 107 · see citing works

Influence of unplanned excisions on the outcomes of patients with stage III extremity soft‐tissue sarcoma

Traub, F., Griffin, A. M., Wunder, J. S., & Ferguson, P. C. (2018) · Cancer · doi:10.1002/cncr.31648 · Cited by 106 · see citing works

Advances in limb salvage treatment of osteosarcoma

Yang, Y., Han, L., He, Z., Li, X., Yang, S., Yang, J., Zhang, Y., Li, D., Yang, Y., & Yang, Z. (2017) · Journal of bone oncology · doi:10.1016/j.jbo.2017.11.005 · Cited by 105 · see citing works

CD163 Is Required for Protumoral Activation of Macrophages in Human and Murine Sarcoma

Shiraishi, D., Fujiwara, Y., Horlad, H., Saito, Y., Iriki, T., Tsuboki, J., Pan, C., Nakagata, N., Mizuta, H., Bekki, H., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2011 · Cited by 105 · see citing works

Flow perfusion effects on three-dimensional culture and drug sensitivity of Ewing sarcoma

Santoro, M., Lamhamedi-Cherradi, S.-E., Menegaz, B. A., Ludwig, J. A., & Mikos, A. G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506684112 · Cited by 104 · see citing works

Soft Tissue Tumor Immunohistochemistry Update: Illustrative Examples of Diagnostic Pearls to Avoid Pitfalls

Wei, S., Henderson‐Jackson, E., Qian, X., & Bui, M. M. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0417-ra · Cited by 103 · see citing works

Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas

Lucchesi, C., Khalifa, E., Laizet, Y., Soubeyran, I., Mathoulin‐Pélissier, S., Chomienne, C., & Italiano, A. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0723 · Cited by 102 · see citing works

Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas

Dancsok, A. R., Setsu, N., Gao, D., Blay, J., Thomas, D. M., Maki, R. G., Nielsen, T. O., & Demicco, E. G. (2019) · Modern Pathology · doi:10.1038/s41379-019-0312-y · Cited by 101 · see citing works

Therapeutic implications of tumor interstitial acidification

Kolosenko, I., Avnet, S., Baldini, N., Viklund, J., & Milito, A. D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.008 · Cited by 100 · see citing works

PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis

Que, Y., Xiao, W. L., Guan, Y., Liang, Y., Yan, S., Chen, H.-Y., Li, Q.-Q., Xu, B.-S., Zhou, Z., & Zhang, X. (2017) · Journal of Cancer · doi:10.7150/jca.18683 · Cited by 100 · see citing works

Mesenchymal stem cell transformation and sarcoma genesis

Xiao, W., Mohseny, A. B., Hogendoorn, P. C. W., & Cleton-Jansen, A. (2013) · Clinical Sarcoma Research · doi:10.1186/2045-3329-3-10 · Cited by 99 · see citing works

Distinct Effects of Ligand-Induced PDGFRα and PDGFRβ Signaling in the Human Rhabdomyosarcoma Tumor Cell and Stroma Cell Compartments

Ehnman, M., Missiaglia, E., Folestad, E. B., Selfe, J., Strell, C., Thway, K., Brodin, B. A., Pietras, K., SHIPLEY, J. M., Östman, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1646 · Cited by 98 · see citing works

Genome‐wide analysis of somatic copy number alterations and chromosomal breakages in osteosarcoma

Smida, J., Xu, H., Zhang, Y., Baumhoer, D., Ribi, S., Kovac, M. B., von Luettichau, I., Bielack, S., O’Leary, V. B., Leib‐Mösch, C., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30778 · Cited by 98 · see citing works

Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion

Cortini, M., Massa, A., Avnet, S., Bonuccelli, G., & Baldini, N. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166500 · Cited by 97 · see citing works

Osteosarcoma

Beird, H. C., Bielack, S. S., Flanagan, A. M., Gill, J., Heymann, D., Janeway, K. A., Livingston, J. A., Roberts, R. D., Strauss, S. J., & Gorlick, R. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00409-y · Cited by 660 · see citing works

Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia

Cruz, A. S., Mendes‐Frias, A., Oliveira, A. I., Dias, L., Matos, A. R., Carvalho, A., Capela, C., Pedrosa, J., Castro, A. G., & Silvestre, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.613422 · Cited by 355 · see citing works

Naringenin: A potential flavonoid phytochemical for cancer therapy

Motallebi, M., Bhia, M., Rajani, H. F., Bhia, I., Tabarraei, H., Mohammadkhani, N., Pereira‐Silva, M., Kasaii, M. S., Nouri-Majd, S., Mueller, A., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120752 · Cited by 336 · see citing works

Ewing Sarcoma—Diagnosis, Treatment, Clinical Challenges and Future Perspectives

Zöllner, S. K., Amatruda, J. F., Bauer, S., Collaud, S., de Álava, E., DuBois, S. G., Hardes, J., Hartmann, W., Kovar, H., Metzler, M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081685 · Cited by 275 · see citing works

Accelerating antibiotic discovery through artificial intelligence

Melo, M. C. R., Maasch, J. R. M. A., & de la Fuente-Nunez, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02586-0 · Cited by 234 · see citing works

Future Directions in the Treatment of Osteosarcoma

Smrke, A., Anderson, P. M., Gulia, A., Gennatas, S., Huang, P. H., & Jones, R. L. (2021) · Cells · doi:10.3390/cells10010172 · Cited by 225 · see citing works

Advances in Osteosarcoma

Panez-Toro, I., Muñoz-García, J., Vargas-Franco, J. W., Renodon‐Cornière, A., Heymann, M., Lézot, F., & Heymann, D. (2023) · Current Osteoporosis Reports · doi:10.1007/s11914-023-00803-9 · Cited by 132 · see citing works

Stem cell membrane-coated abiotic nanomaterials for biomedical applications

Ferreira-Faria, I., Yousefiasl, S., Macário‐Soares, A., Pereira‐Silva, M., Peixoto, D., Zafar, H., Raza, F., Faneca, H., Veiga, F., Hamblin, M. R., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.012 · Cited by 119 · see citing works

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies

Hattinger, C. M., Patrizio, M. P., Fantoni, L., Casotti, C., Riganti, C., & Serra, M. (2021) · Cancers · doi:10.3390/cancers13122878 · Cited by 110 · see citing works

Bacteria as a treasure house of secondary metabolites with anticancer potential

Mohan, C. D., Rangappa, S., Nayak, S. C., Jadimurthy, R., Wang, L., Sethi, G., Garg, M., & Rangappa, K. S. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.006 · Cited by 100 · see citing works

Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies

Zarrabi, A., Perrin, D., Kavoosi, M., Sommer, M., Sezen, S., Mehrbod, P., Bhushan, B., Machaj, F., Rosik, J., Kawalec, P., et al. (2023) · Cancers · doi:10.3390/cancers15215269 · Cited by 88 · see citing works

Chondrosarcoma-from Molecular Pathology to Novel Therapies

Zając, A. E., Kopeć, S., Szostakowski, B., Spalek, M. J., Fiedorowicz, M., Bylina, E., Filipowicz, P., Szumera‐Ciećkiewicz, A., Tysarowski, A., Czarnecka, A. M., et al. (2021) · Cancers · doi:10.3390/cancers13102390 · Cited by 84 · see citing works

Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level

Pillozzi, S., Bernini, A., Palchetti, I., Crociani, O., Antonuzzo, L., Campanacci, D. A., & Scoccianti, G. (2021) · Cancers · doi:10.3390/cancers13123044 · Cited by 76 · see citing works

The landscape of drug sensitivity and resistance in sarcoma

Shihabi, A. A., Tebon, P. J., Nguyen, H. T. L., Chantharasamee, J., Sartini, S., Davarifar, A., Jensen, A. Y., Diaz-Infante, M. B., Cox, H., Gonzalez, A. E., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.08.010 · Cited by 75 · see citing works

Compensatory evolution of Pseudomonas aeruginosa’s slow growth phenotype suggests mechanisms of adaptation in cystic fibrosis

Rosa, R. L., Rossi, E., Feist, A. M., Johansen, H. K., & Molin, S. (2021) · Nature Communications · doi:10.1038/s41467-021-23451-y · Cited by 72 · see citing works

TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation

Magno, L., Bunney, T. D., Mead, E., Svensson, F., & Bictash, M. N. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00436-5 · Cited by 64 · see citing works

Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy

Taurin, S., Alzahrani, R., Aloraibi, S., Ashi, L., AlHarmi, R. A. R., & Hassani, N. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102226 · Cited by 54 · see citing works

Single-cell RNA-seq of a soft-tissue sarcoma model reveals the critical role of tumor-expressed MIF in shaping macrophage heterogeneity

Tessaro, F. H. G., Ko, E. Y., Simone, M. C. D., Piras, R., Broz, M. T., Goodridge, H. S., Balzer, B. L., Shiao, S. L., & Guarnerio, J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110977 · Cited by 50 · see citing works

Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and Osteosarcoma

Evdokimova, V. E., Gassmann, H., Radvanyi, L. G., & Burdach, S. E. G. (2022) · Cancers · doi:10.3390/cancers15010272 · Cited by 54 · see citing works

Retroperitoneal Sarcoma Care in 2021

Schmitz, E. M., & Nessim, C. (2022) · Cancers · doi:10.3390/cancers14051293 · Cited by 52 · see citing works

Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas

Menéndez, S. T., Gallego, B., Murillo, D., Rodríguez, A., & Rodrı́guez, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122621 · Cited by 48 · see citing works

Small round cell sarcomas

Cidre‐Aranaz, F., Watson, S., Amatruda, J. F., Nakamura, T., Delattre, O., de Álava, E., Dirksen, U., & Grünewald, T. G. P. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00393-3 · Cited by 48 · see citing works

The YAP/TEAD Axis as a New Therapeutic Target in Osteosarcoma: Effect of Verteporfin and CA3 on Primary Tumor Growth

Morice, S., Mullard, M., Brion, R., Dupuy, M., Renault, S., Tesfaye, R. A., Royer, B. B.-L., Ory, B., Rédiní, F., & Verrecchia, F. (2020) · Cancers · doi:10.3390/cancers12123847 · Cited by 44 · see citing works

Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures

Wakamatsu, T., Ogawa, H., Yoshida, K., Matsuoka, Y., Shizuma, K., Imura, Y., Tamiya, H., Nakai, S., Yagi, T., Nagata, S., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.893592 · Cited by 43 · see citing works

Artificial intelligence and the future of life sciences

Leite, M. L., Costa, L. S. D. L., Cunha, V. A., Kreniski, V., Filho, M. D. O. B., da Cunha, N. B., & Costa, F. F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.07.002 · Cited by 46 · see citing works

Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives

Jarak, I., Pereira‐Silva, M., Paiva‐Santos, A. C., Veiga, F., Cabral, H., & Figueiras, A. (2021) · Applied Materials Today · doi:10.1016/j.apmt.2021.101217 · Cited by 40 · see citing works

Overexpression of the Ubiquitin Specific Proteases USP43, USP41, USP27x and USP6 in Osteosarcoma Cell Lines: Inhibition of Osteosarcoma Tumor Growth and Lung Metastasis Development by the USP Antagonist PR619

Lavaud, M., Mullard, M., Tesfaye, R. A., Amiaud, J., Legrand, M., Danieau, G., Brion, R., Morice, S., Regnier, L., Dupuy, M., et al. (2021) · Cells · doi:10.3390/cells10092268 · Cited by 38 · see citing works

Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need

Vanni, S., Fausti, V., Fonzi, E., Liverani, C., Miserocchi, G., Spadazzi, C., Cocchi, C., Calabrese, C., Gurrieri, L., Riva, N., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086926 · Cited by 37 · see citing works

Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma

Morales‐Molina, Á., Gambera, S., Leo, A., & Garcı́a-Castro, J. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001703 · Cited by 37 · see citing works

Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials

Tang, F., Tie, Y., Wei, Y.-Q., Tu, C., & Wei, X. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188606 · Cited by 37 · see citing works

Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targeting

Rufo, N., Korovesis, D., Eygen, S. V., Derua, R., Garg, A. D., Finotello, F., Vara‐Pérez, M., Rožanc, J., Dewaele, M., de Witte, P. A. M., et al. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-021-00853-5 · Cited by 37 · see citing works

The Role of Keratin17 in Human Tumours

Zhang, H., Zhang, Y., Xia, T., Lu, L., Luo, M., Chen, Y., Liu, Y., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.818416 · Cited by 38 · see citing works

ANGPTL4 accelerates KRASG12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis

YAN, H. H., Jung, K. H., Lee, J. E., Son, M. K., Fang, Z., Park, J. H., Kim, S., Kim, J., Lim, J. H., & Hong, S. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.036 · Cited by 36 · see citing works

Next-generation sequencing for the management of sarcomas with no known driver mutations

Vyse, S., Thway, K., Huang, P. H., & Jones, R. L. (2021) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000741 · Cited by 36 · see citing works

USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response

Prokakis, E., Dyas, A., Grün, R., Fritzsche, S., Bedi, U., Kazerouni, Z. B., Kosinsky, R. L., Johnsen, S. A., & Wegwitz, F. (2021) · Oncogene · doi:10.1038/s41388-021-01814-5 · Cited by 35 · see citing works

The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma

Avnet, S., Lemma, S., Cortini, M., Pompo, G. D., Perut, F., Lipreri, M. V., Roncuzzi, L., Columbaro, M., Errani, C., Longhi, A., et al. (2021) · Cancers · doi:10.3390/cancers13225855 · Cited by 36 · see citing works

Acid Microenvironment in Bone Sarcomas

Pompo, G. D., Cortini, M., Baldini, N., & Avnet, S. (2021) · Cancers · doi:10.3390/cancers13153848 · Cited by 32 · see citing works

An External-Validated Prediction Model to Predict Lung Metastasis among Osteosarcoma: A Multicenter Analysis Based on Machine Learning

Li, W., Liu, W., Memon, F. H., Wang, B., Xu, C., Dong, S., Wang, H., Hu, Z., Quan, X., Deng, Y., et al. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/2220527 · Cited by 32 · see citing works

The emerging role of cancer nanotechnology in the panorama of sarcoma

Mercatali, L., Vanni, S., Miserocchi, G., Liverani, C., Spadazzi, C., Cocchi, C., Calabrese, C., Gurrieri, L., Fausti, V., Riva, N., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.953555 · Cited by 33 · see citing works

Sarcoma care in the era of precision medicine

Wallander, K., Öfverholm, I., Boye, K., Tsagkozis, P., Papakonstantinou, A., Lin, Y., & Haglund de Flon, F. (2023) · Journal of Internal Medicine · doi:10.1111/joim.13717 · Cited by 30 · see citing works

Targeting metastasis in paediatric bone sarcomas

Bull, E. C., Singh, A., Harden, A. M., Soanes, K., Habash, H., Toracchio, L., Carrabotta, M., Schreck, C., Shah, K. M., Riestra, P. V., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02365-z · Cited by 30 · see citing works

Metabolism of cancer cells commonly responds to irradiation by a transient early mitochondrial shutdown

Krysztofiak, A., Szymonowicz, K., Hlouschek, J., Xiang, K., Waterkamp, C., Larafa, S., Goetting, I., Vega-Rubín-de-Celis, S., Theiß, C., Matschke, V., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103366 · Cited by 29 · see citing works

PROTAC-Based Protein Degradation as a Promising Strategy for Targeted Therapy in Sarcomas

Mancarella, C., Morrione, A., & Scotlandi, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216346 · Cited by 28 · see citing works

Hypofractionated Radiation Therapy for Unresectable or Metastatic Sarcoma Lesions

Boyce-Fappiano, D. R., Damron, E. P., Farooqi, A. S., Mitra, D., Conley, A. P., Somaiah, N., Araujo, D. M., Livingston, J. A., Ratan, R., Keung, E. Z.-Y., et al. (2022) · Advances in Radiation Oncology · doi:10.1016/j.adro.2022.100913 · Cited by 27 · see citing works

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors

Lanzi, C., Arrighetti, N., Pasquali, S., & Cassinelli, G. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115727 · Cited by 27 · see citing works

The Sarcoma Immune Landscape: Emerging Challenges, Prognostic Significance and Prospective Impact for Immunotherapy Approaches

Koumarianou, A. A., & Durán, J. (2021) · Cancers · doi:10.3390/cancers13030363 · Cited by 26 · see citing works

Tumor and Peripheral Immune Status in Soft Tissue Sarcoma: Implications for Immunotherapy

Sousa, L. M., Almeida, J. S., Fortes-Andrade, T., Santos-Rosa, M., Freitas-Tavares, P., Casanova, J., & Rodrigues‐Santos, P. (2021) · Cancers · doi:10.3390/cancers13153885 · Cited by 26 · see citing works

Mithramycin delivery systems to develop effective therapies in sarcomas

Estupiñán, Ó., Niza, E., Bravo, I., Rey, V., Tornín, J., Gallego, B., Clemente-Casares, P., Morís, F., Ocaña, A., Blanco‐Lorenzo, V., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01008-x · Cited by 26 · see citing works

YBX1-interacting small RNAs and RUNX2 can be blocked in primary bone cancer using CADD522

Green, D., Singh, A., Tippett, V. L., Tattersall, L., Shah, K. M., Siachisumo, C., Ward, N. J., Thomas, P., Carter, S., Jeys, L. M., et al. (2023) · Journal of bone oncology · doi:10.1016/j.jbo.2023.100474 · Cited by 24 · see citing works

Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma

Tornín, J., Mateu‐Sanz, M., Rey, V., Murillo, D., Huergo, C., Gallego, B., Rodríguez, A., Rodrı́guez, R., & Canal, C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102685 · Cited by 25 · see citing works

Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update

Patrichi, A. I., & Gurzu, S. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155406 · Cited by 24 · see citing works

Neoadjuvant Chemotherapy for Adults with Osteogenic Sarcoma

Robinson, M. J., & Davis, E. J. (2024) · Current Treatment Options in Oncology · doi:10.1007/s11864-024-01269-2 · Cited by 24 · see citing works

G1-phase progression in pluripotent stem cells

ter Huurne, M., & Stunnenberg, H. G. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03797-8 · Cited by 22 · see citing works

Advances in sarcoma molecular diagnostics

Wang, X. Q., Goytain, A., Dickson, B. C., & Nielsen, T. O. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23025 · Cited by 22 · see citing works

The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma

Thiel, J. T., Daigeler, A., Kolbenschlag, J., Rachunek, K., & Hoffmann, S. (2022) · Cancers · doi:10.3390/cancers14143380 · Cited by 22 · see citing works

Noncanonical roles of p53 in cancer stemness and their implications in sarcomas

Curylova, L., Ramos, H., Saraiva, L., & Skoda, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.10.037 · Cited by 21 · see citing works

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

Hagelstein, I., Engel, M., Hinterleitner, C., Manz, T., Märklin, M., Jung, G., Salih, H. R., & Zekri, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1002898 · Cited by 20 · see citing works

Assessment of Environmental and Occupational Risk Factors for the Mitigation and Containment of a COVID-19 Outbreak in a Meat Processing Plant

Walshe, N., Fennelly, M., Hellebust, S., Wenger, J., Sodeau, J. R., Prentice, M. B., Grice, C., Jordan, V., Comerford, J., Downey, V., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.769238 · Cited by 19 · see citing works

Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma

Jubelin, C., Muñoz-García, J., Cochonneau, D., Moranton, E., Heymann, M., & Heymann, D. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.130 · Cited by 19 · see citing works

Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients

Heymann, C. J. F., Bobin‐Dubigeon, C., Muñoz-García, J., Cochonneau, D., Ollivier, E., Heymann, M., & Heymann, D. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100451 · Cited by 19 · see citing works

Combinatorial strategies to potentiate the efficacy of HDAC inhibitors in fusion-positive sarcomas

Lanzi, C., & Cassinelli, G. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114944 · Cited by 18 · see citing works

Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes

Baelen, J., Dewaele, B., Dêbiec‐Rychter, M., Sciot, R., Schöffski, P., Hompes, D., Sinnaeve, F., Wafa, H., & Bempt, I. V. (2024) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2024.02.003 · Cited by 18 · see citing works

Targeting the aryl hydrocarbon receptor with a novel set of triarylmethanes

Goya‐Jorge, E., Rampal, C., Loones, N., Barigye, S. J., Carpio, L. E., Gozalbes, R., Ferroud, C., Veitía, M. S., & Giner, R. M. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112777 · Cited by 18 · see citing works

Evaluation of virucidal activity of residual quaternary ammonium-treated surfaces on SARS-CoV-2

Caschera, A. G., McAuley, J., Kim, Y., Purcell, D. F. J., Rymenants, J., & Foucher, D. A. (2021) · American Journal of Infection Control · doi:10.1016/j.ajic.2021.10.021 · Cited by 18 · see citing works

A review: antimicrobial resistance data mining models and prediction methods study for pathogenic bacteria

Li, X., Zhang, Z., Liang, B., Ye, F., & Gong, W. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00471-w · Cited by 18 · see citing works

A novel tumor inhibitory hybridoma monoclonal antibody with dual specificity for HER3 and HER2

Hassani, D., Amiri, M. M., Mohammadi, M., Yousefi, P., Judaki, M. A., Mobini, M., Golsaz‐Shirazi, F., Jeddi‐Tehrani, M., & Shokri, F. (2021) · Current Research in Translational Medicine · doi:10.1016/j.retram.2021.103277 · Cited by 17 · see citing works

Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations

Imle, R., Kommoss, F. K. F., & Banito, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081578 · Cited by 16 · see citing works

Application of Multi-Omics Approach in Sarcomas: A Tool for Studying Mechanism, Biomarkers, and Therapeutic Targets

Zou, Z., Sun, W. Y., Xu, Y., Liu, W., Zhong, J., Lin, X., & Chen, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.946022 · Cited by 17 · see citing works

The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas

Holzmayer, S. J., Liebel, K., Hagelstein, I., Salih, H. R., & Märklin, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1391954 · Cited by 17 · see citing works

Nano-Encapsulation of Mithramycin in Transfersomes and Polymeric Micelles for the Treatment of Sarcomas

Estupiñán, Ó., Rendueles, C., Suárez, P., Rey, V., Murillo, D., Morís, F., Gutiérrez, G., Blanco‐López, M. C., Matos, M., & Rodrı́guez, R. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071358 · Cited by 17 · see citing works

Addressing Doxorubicin Resistance in Bone Sarcomas Using Novel Drug-Resistant Models

Gallego, B., Murillo, D., Rey, V., Huergo, C., Estupiñán, Ó., Rodríguez, A., Tornín, J., & Rodrı́guez, R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126425 · Cited by 16 · see citing works

Regorafenib for the Treatment of Sarcoma

Blay, J., Duffaud, F., George, S., Maki, R. G., & Penel, N. (2022) · Current Treatment Options in Oncology · doi:10.1007/s11864-022-00990-0 · Cited by 17 · see citing works

Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma

Walker, R. L., Hornicek, F. J., & Duan, Z. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116342 · Cited by 16 · see citing works

The molecular conversations of sarcomas: exosomal non-coding RNAs in tumor’s biology and their translational prospects

Luongo, M., Laurenziello, P., Cesta, G., Bochicchio, A. M., Omer, L. C., Falco, G., Milone, M. R., Cibarelli, F., Russi, S., & Laurino, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02083-y · Cited by 16 · see citing works

Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma

Schöffski, P., Bahleda, R., Wagner, A. J., Burgess, M. A., Junker, N., Chisamore, M. J., Peterson, P. M., Szpurka, A. M., Ceccarelli, M., & Tap, W. D. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0742 · Cited by 15 · see citing works

Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma

Leng, D., Yang, Z., Sun, H., Song, C., Huang, C., Ip, K. U., Chen, G., Deng, C., Zhang, X. D., & Zhao, Q. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-3396 · Cited by 15 · see citing works

Patients’ Experiences of a Sarcoma Diagnosis: A Process Mapping Exercise of Diagnostic Pathways

Martin, S., Clark, S. E., Gerrand, C., Gilchrist, K., Lawal, M., Maio, L., Martins, A. P., Storey, L., Taylor, R. M., Wells, M., et al. (2023) · Cancers · doi:10.3390/cancers15153946 · Cited by 15 · see citing works

Sarcoma Immunotherapy: Confronting Present Hurdles and Unveiling Upcoming Opportunities

Jeong, S., Afroz, S., Kang, D., Noh, J., Suh, J., Kim, J. H., You, H. J., Kang, H. G., Kim, Y., & Kim, J. (2023) · Molecules and Cells · doi:10.14348/molcells.2023.0079 · Cited by 15 · see citing works

Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics

Lee, C., The, M., Meng, C., Bayer, F. P., Putzker, K., Müller, J., Streubel, J., Woortman, J., Sakhteman, A., Moritz, R., et al. (2023) · Molecular Systems Biology · doi:10.1038/s44320-023-00004-7 · Cited by 15 · see citing works

Precision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas

Barghi, F., Shannon, H. E., Saadatzadeh, M. R., Bailey, B. J., Riyahi, N., Bijangi‐Vishehsaraei, K., Just, M., Ferguson, M. J., Pandya, P. H., & Pollok, K. E. (2022) · Cancers · doi:10.3390/cancers14153611 · Cited by 15 · see citing works

Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue Sarcomas

Chodyla, M.-K., Demircioğlu, A., Schaarschmidt, B. M., Bertram, S., Morawitz, J., Bauer, S., Podleska, L. E., Rischpler, C., Forsting, M., Herrmann, K., et al. (2021) · Cancers · doi:10.3390/cancers13112753 · Cited by 15 · see citing works

MEK1/2 activity modulates TREM2 cell surface recruitment

Schapansky, J., Grinberg, Y. Y., Osiecki, D. M., Freeman, E. A., Walker, S. G., Karran, E. H., Gopalakrishnan, S. M., & Talanian, R. V. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014352 · Cited by 14 · see citing works

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas

Hagelstein, I., Lutz, M. S., Schmidt, M. J., Heitmann, J. S., Malenke, E., Zhou, Y., Clar, K. L., Kopp, H., Jung, G., Salih, H. R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653081 · Cited by 14 · see citing works

Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma

Stillger, M. N., Li, M. J., Hönscheid, P., von Neubeck, C., & Föll, M. C. (2024) · PROTEOMICS · doi:10.1002/pmic.202300001 · Cited by 15 · see citing works

A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma

Rey, V., Tornín, J., Alba‐Linares, J. J., Robledo, C., Murillo, D., Rodríguez, A., Gallego, B., Huergo, C., Viera, C., Braña, A., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105090 · Cited by 16 · see citing works

Prime Editing: An Emerging Tool in Cancer Treatment

Sen, D., Sarkar, S., & Mukhopadhyay, P. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00580-3 · Cited by 13 · see citing works

Xenografting Human Musculoskeletal Sarcomas in Mice, Chick Embryo, and Zebrafish: How to Boost Translational Research

Giusti, V., Miserocchi, G., Sbanchi, G., Pannella, M., Hattinger, C. M., Cesari, M., Fantoni, L., Guerrieri, A. N., Bellotti, C., Vita, A. D., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12081921 · Cited by 12 · see citing works

Signal Pathways and microRNAs in Osteosarcoma Growth and the Dual Role of Mesenchymal Stem Cells in Oncogenesis

Тодосенко, Н. М., Хлусов, И. А., Yurova, K. A., Геннадьевна, Х. О., & Litvinova, L. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108993 · Cited by 12 · see citing works

Clinical Differences Among Histological Categories of Sarcoma: Insights from 97,062 Patients

Han, Y., Shah, A., Yao, Y., Mutter, R. W., & Xu‐Welliver, M. (2025) · Cancers · doi:10.3390/cancers17101706 · Cited by 11 · see citing works

Retrospective immunohistochemical investigation of suspected non-visceral leiomyosarcoma in dogs

Brady, R. V., Rebhun, R. B., Skorupski, K. A., Burton, J. H., Al‐Nadaf, S., Choi, E., & Willcox, J. L. (2022) · Journal of Veterinary Diagnostic Investigation · doi:10.1177/10406387221083570 · Cited by 11 · see citing works

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma

Tu, C., Liu, B., Li, C., Feng, C., Wang, H., Zhang, H., He, S., & Li, Z. (2023) · MedComm · doi:10.1002/mco2.369 · Cited by 10 · see citing works

Classification of pediatric soft and bone sarcomas using DNA methylation-based profiling

Silva, F. L. T., Euzébio, M. F., Ruas, J. S., Franco, M. T., Cassone, A. E., Junqueira, T., Lucon, D. R., Cardinalli, I. A., Pereira, L. H., Zenatti, P. P., et al. (2024) · BMC Cancer · doi:10.1186/s12885-024-13159-9 · Cited by 10 · see citing works

Primary central nervous system sarcomas in adults: A systematic review

Haider, A. S., Palmisciano, P., Sagoo, N. S., Bin-Alamer, O., Ahmadieh, T. Y. E., Pan, E., & Garzón-Muvdi, T. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107127 · Cited by 10 · see citing works

Proof of concept for the use of trained sniffer dogs to detect osteosarcoma

Ortal, A., Rodríguez, A., Solís-Hernández, M. P., de Prado, M., Rey, V., Tornín, J., Estupiñán, Ó., Gallego, B., Murillo, D., Huergo, C., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-11013-1 · Cited by 10 · see citing works

Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)

Moyers, J. T., Pestana, R. C., Roszik, J., Hong, D. S., Naing, A., Fu, S., Piha-Paul, S. A., Yap, T. A., Karp, D. D., Rodon, J. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2509 · Cited by 10 · see citing works

A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review

Zhang, L., Zhang, G., Zheng, H., Jiang, B., Ju, Y., Duan, Q., An, L., & Shi, H. (2023) · Brain Tumor Pathology · doi:10.1007/s10014-023-00471-8 · Cited by 10 · see citing works

Clinical biomarkers in soft tissue sarcoma A comprehensive review of current soft tissue sarcoma biomarkers

Sharma, S. R., Paonessa, N. E., Casadei, L., de Faria, F. C., Pollock, R. E., & Grignol, V. P. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26680 · Cited by 10 · see citing works

Current challenges and practical aspects of molecular pathology for bone and soft tissue tumors

de Álava, E. (2024) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-024-03736-5 · Cited by 9 · see citing works

Well-differentiated liposarcomas and dedifferentiated liposarcomas: Systemic treatment options for two sibling neoplasms

Kyriazoglou, A. I., Pagkali, A., Kotsantis, I., Economopoulou, P., Kyrkasiadou, M., Moutafi, M. K., Gavrielatou, N., Anastasiou, Μ., Boulouta, A., Pantazopoulos, A., et al. (2024) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2024.102716 · Cited by 9 · see citing works

Managing sarcoma: where have we come from and where are we going?

Bleloch, J., Ballim, R. D., Kimani, S., Parkes, J., Panieri, E., Willmer, T., & Prince, S. (2017) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834017728927 · Cited by 68 · see citing works

Biology of Bone and Soft Tissue Sarcoma: From Molecular Features to Clinical Applications

Watson, S., & Delattre, O. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65255-8

More Than 50 Subtypes of Soft Tissue Sarcoma: Paving the Path for Histology-Driven Treatments

Katz, D., Palmerini, E., & Pollack, S. M. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_205423 · Cited by 98 · see citing works

Sarcoma: Molecular-Targeted Therapies

Yonemori, K. (2012) · Annals of Oncology · doi:10.1016/s0923-7534(20)32116-5

Clinicopathologic Considerations: How Can We Fine Tune Our Approach to Sarcoma?

Demicco, E. G., & Lazar, A. J. (2011) · Seminars in Oncology · doi:10.1053/j.seminoncol.2011.09.001 · Cited by 18 · see citing works